Clinical Trial Update: Dialysis Clinical Outcomes Revisited (DCOR) Trial [Phase 4]

View source ↗

Summary

This clinical trial update reports on Phase 4 results from the Dialysis Clinical Outcomes Revisited (DCOR) trial. It examines outcomes associated with different…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• ARANESP (DARBEPOETIN ALFA)

Snippet

Sponsor: Genzyme, a Sanofi Company | Conditions: Chronic Kidney Disease | Phase 4 | Status: COMPLETED